We help countries build strong health systems, complete with the laboratories, information systems, clinics, and well-trained staff they need to prevent, detect, and stop disease outbreaks before they can become epidemics or pandemics.
Widespread vaccination is the surest way to halt vaccine-derived poliovirus outbreaks, a tenacious threat of the pre-eradication era.
Vietnam has been working for nearly a decade to develop and manufacture influenza vaccines. With PATH support, the Institute of Vaccines and Medical Biologicals has done just that—and it has submitted two candidates for licensure.
How does Vietnam's work on a seasonal influenza vaccine mitigate deadly pandemics?
As a nine-year project to build vaccine development capacity worldwide comes to an end, PATH and partners reflect on how far we’ve come.
Serbia’s Institute of Virology, Vaccines, and Sera “Torlak” is a trusted, recognized vaccine producer in Serbia. As part of the influenza vaccine development project, it conducted its first complex vaccine clinical trial in humans, which helps position Torlak as an essential vaccine producer for the Balkan region.